THREE of the most dangerous medicines in the world have been revealed – and millions of Brits already use them. A cold and ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

patients need to be treated in a doctor’s office or hospital setting and remain in the clinic until the side effects have passed. The nasal spray has been administered to more than 140,000 ...

A one-time nasal spray has been approved by the Food and Drug Administration ... It's related to the drug ketamine, which can cause hallucinations and sedation. Because of the adverse side effects, it ...